Scabini S, Rimini E, Romairone E, Scordamaglia R, Pertile D, Ferrando V
Operative Unit of Oncological Surgery and Implantable System Surgery, S. Martino University Hospital, Genoa, Italy.
Minerva Chir. 2010 Feb;65(1):17-20.
In this study, we analyze clinical parameters, survival and possible advantage of surgery in patients affected by symptomatic Dukes D colorectal cancer.
From July 2005 to December 2008 at our Oncological Surgery Unit we treated 69 symptomatic stage IV CRC, 46 of them resected at our Oncological Surgical Unit. Clinical variables were tested for their relationship to survival in a univariate prognostic analysis and revealed the interaction of the prognostic factors.
In symptomatic stage IV CRC with non-curable resection, the most robust univariate predictor for poor prognosis was impossibility to cancer resection. It is associated with significative decrease of survival also in the short term. In our series we do not observe correlation between poor prognosis and age, gender, localisation of tumor, depth of invasion, 19.9 and surgeons. CEA more than 100 microg/L and impossibility to adiuvant therapy have a significative role and are associated with poor prognosis.
Our results suggested that impossibility to perform cancer resection is associated with poor prognosis in symptomatic stage IV CRC and worse survival also in the short term.
在本研究中,我们分析了有症状的Dukes D期结直肠癌患者的临床参数、生存率以及手术可能带来的益处。
2005年7月至2008年12月期间,我们肿瘤外科治疗了69例有症状的IV期结直肠癌患者,其中46例在我们肿瘤外科接受了手术切除。在单因素预后分析中测试临床变量与生存率的关系,并揭示预后因素之间的相互作用。
在有症状的IV期结直肠癌且无法治愈性切除的患者中,预后不良最有力的单因素预测指标是无法进行癌症切除。这也与短期内生存率的显著下降相关。在我们的系列研究中,未观察到预后不良与年龄、性别、肿瘤位置、浸润深度、19.9以及外科医生之间存在相关性。癌胚抗原(CEA)高于100μg/L以及无法进行辅助治疗具有显著作用,且与预后不良相关。
我们的结果表明,无法进行癌症切除与有症状的IV期结直肠癌患者预后不良相关,且短期内生存率更低。